YAP1 and hepatocellular carcinoma: Evodiamine decreased the expression of YAP1 and the growth of HCC cells in a dose-dependent manner, then induced apoptosis, inhibited tumor cell migration, invasion and epithelial-to-mesenchymal cell transition through YAP1 (183).